{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T06:59:36Z","timestamp":1790233176957,"version":"4.1.0"},"reference-count":44,"publisher":"Informa UK Limited","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["www.tandfonline.com"],"crossmark-restriction":true},"short-container-title":["Emerging Microbes & Infections"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1038\/emi.2017.29","type":"journal-article","created":{"date-parts":[[2017,6,7]],"date-time":"2017-06-07T07:21:11Z","timestamp":1496820071000},"page":"1-8","update-policy":"https:\/\/doi.org\/10.1080\/tandf_crossmark_01","source":"Crossref","is-referenced-by-count":25,"title":["Seroprevalence of neutralizing antibodies against adenovirus type 14 and 55 in healthy adults in Southern China"],"prefix":"10.1080","volume":"6","author":[{"given":"Xuehua","family":"Zheng","sequence":"first","affiliation":[{"name":"State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China"},{"name":"Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xia","family":"Rong","sequence":"additional","affiliation":[{"name":"Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou 510095, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Feng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China"},{"name":"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xikui","family":"Sun","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Li","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China"},{"name":"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wang","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Min","family":"Wang","sequence":"additional","affiliation":[{"name":"Institute of Clinical Blood Transfusion, Guangzhou Blood Center, Guangzhou 510095, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenkuan","family":"Liu","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chufang","family":"Li","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyu","family":"Yang","sequence":"additional","affiliation":[{"name":"Pediatric Intensive Care Unit, Guangzhou Women and Children\u2019s Medical Center, Guangzhou 510180, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[{"name":"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiahai","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics and Epidemiology, School of Public Health, Sun Yat-sen University, Guangzhou 510080, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liqiang","family":"Feng","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Chen","sequence":"additional","affiliation":[{"name":"State Key Laboratory of Respiratory Diseases, Guangzhou Institutes of Biomedicine and Health, Chinese Academy of Sciences, Guangzhou 510530, China"},{"name":"The First Affiliated Hospital of Guangzhou Medical University, Guangzhou 510230, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"301","published-online":{"date-parts":[[2019,1,15]]},"reference":[{"key":"e_1_3_2_2_1","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1099\/vir.0.19497-0","article-title":"Genetic content and evolution of adenoviruses","volume":"84","author":"Davison AJ","year":"2003","unstructured":"Davison AJ, Benko M, Harrach B.Genetic content and evolution of adenoviruses. J Gen Virol 2003;84: 2895\u20132908.","journal-title":"J Gen Virol"},{"key":"e_1_3_2_3_1","doi-asserted-by":"crossref","first-page":"e0151199","DOI":"10.1371\/journal.pone.0151199","article-title":"Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: a multicenter case series","volume":"11","author":"Tan D","year":"2016","unstructured":"Tan D, Zhu H, Fu Yet al.Severe community-acquired pneumonia caused by human adenovirus in immunocompetent adults: a multicenter case series. PLoS One 2016;11: e0151199.","journal-title":"PLoS One"},{"key":"e_1_3_2_4_1","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11908-010-0084-5","article-title":"The role of adenovirus in respiratory tract infections","volume":"12","author":"Kunz AN","year":"2010","unstructured":"Kunz AN, Ottolini M.The role of adenovirus in respiratory tract infections. Curr Infect Dis Rep 2010;12: 81\u201387.","journal-title":"Curr Infect Dis Rep"},{"key":"e_1_3_2_5_1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/978-1-4419-0981-7_13","article-title":"Adenovirus infection in the immunocompromised host","volume":"659","author":"Tebruegge M","year":"2010","unstructured":"Tebruegge M, Curtis N.Adenovirus infection in the immunocompromised host. Adv Exp Med Biol 2010;659: 153\u2013174.","journal-title":"Adv Exp Med Biol"},{"key":"e_1_3_2_6_1","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1002\/jmv.20441","article-title":"Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey","volume":"77","author":"Chmielewicz B","year":"2005","unstructured":"Chmielewicz B, Benzler J, Pauli Get al.Respiratory disease caused by a species B2 adenovirus in a military camp in Turkey. J Med Virol 2005;77: 232\u2013237.","journal-title":"J Med Virol"},{"key":"e_1_3_2_7_1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1086\/598521","article-title":"A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14","volume":"199","author":"Lewis PF","year":"2009","unstructured":"Lewis PF, Schmidt MA, Lu Xet al.A community-based outbreak of severe respiratory illness caused by human adenovirus serotype 14. J Infect Dis 2009;199: 1427\u20131434.","journal-title":"J Infect Dis"},{"key":"e_1_3_2_8_1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1743-422X-10-271","article-title":"Prevalence of adenovirus in children with acute respiratory tract infection in Lanzhou, China","volume":"10","author":"Jin Y","year":"2013","unstructured":"Jin Y, Zhang RF, Xie ZPet al.Prevalence of adenovirus in children with acute respiratory tract infection in Lanzhou, China. Virol J 2013;10: 271.","journal-title":"Virol J"},{"key":"e_1_3_2_9_1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1111\/irv.12232","article-title":"Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009-2012","volume":"8","author":"Lu QB","year":"2014","unstructured":"Lu QB, Tong YG, Wo Yet al.Epidemiology of human adenovirus and molecular characterization of human adenovirus 55 in China, 2009-2012. Influenza Other Respir Viruses 2014;8: 302\u2013308.","journal-title":"Influenza Other Respir Viruses"},{"key":"e_1_3_2_10_1","doi-asserted-by":"crossref","first-page":"e0121375","DOI":"10.1371\/journal.pone.0121375","article-title":"Adenoviruses associated with acute respiratory diseases reported in Beijing from 2011 to 2013","volume":"10","author":"Chen M","year":"2015","unstructured":"Chen M, Zhu Z, Huang Fet al.Adenoviruses associated with acute respiratory diseases reported in Beijing from 2011 to 2013. PLoS One 2015;10: e0121375.","journal-title":"PLoS One"},{"key":"e_1_3_2_11_1","first-page":"119","article-title":"Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in the Netherlands","volume":"65","author":"Vanderveen J","year":"1957","unstructured":"Vanderveen J, Kok G.Isolation and typing of adenoviruses recovered from military recruits with acute respiratory disease in the Netherlands. Am J Hyg 1957;65: 119\u2013129.","journal-title":"Am J Hyg"},{"key":"e_1_3_2_12_1","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1086\/522970","article-title":"Abrupt emergence of diverse species B adenoviruses at US military recruit training centers","volume":"196","author":"Metzgar D","year":"2007","unstructured":"Metzgar D, Osuna M, Kajon AEet al.Abrupt emergence of diverse species B adenoviruses at US military recruit training centers. J Infect Dis 2007;196: 1465\u20131473.","journal-title":"J Infect Dis"},{"key":"e_1_3_2_13_1","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1111\/irv.12118","article-title":"Outbreak of febrile respiratory illness associated with human adenovirus type 14p1 in Gansu Province, China","volume":"7","author":"Huang G","year":"2013","unstructured":"Huang G, Yu D, Zhu Zet al.Outbreak of febrile respiratory illness associated with human adenovirus type 14p1 in Gansu Province, China. Influenza Other Respir Viruses 2013;7: 1048\u20131054.","journal-title":"Influenza Other Respir Viruses"},{"key":"e_1_3_2_14_1","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1086\/653083","article-title":"Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States","volume":"202","author":"Kajon AE","year":"2010","unstructured":"Kajon AE, Lu X, Erdman DDet al.Molecular epidemiology and brief history of emerging adenovirus 14-associated respiratory disease in the United States. J Infect Dis 2010;202: 93\u2013103.","journal-title":"J Infect Dis"},{"key":"e_1_3_2_15_1","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3201\/1708.101760","article-title":"Deaths associated with human adenovirus-14p1 infections, Europe, 2009-2010","volume":"17","author":"Carr MJ","year":"2011","unstructured":"Carr MJ, Kajon AE, Lu Xet al.Deaths associated with human adenovirus-14p1 infections, Europe, 2009-2010. Emerg Infect Dis 2011;17: 1402\u20131408.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_16_1","doi-asserted-by":"crossref","first-page":"e60345","DOI":"10.1371\/journal.pone.0060345","article-title":"Genome and bioinformatic analysis of a HAdV-B14p1 virus isolated from a baby with pneumonia in Beijing, China","volume":"8","author":"Tang L","year":"2013","unstructured":"Tang L, An J, Xie Zet al.Genome and bioinformatic analysis of a HAdV-B14p1 virus isolated from a baby with pneumonia in Beijing, China. PLoS One 2013;8: e60345.","journal-title":"PLoS One"},{"key":"e_1_3_2_17_1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.jcv.2016.03.002","article-title":"Outbreak of adenovirus type 55 infection in Israel","volume":"78","author":"Salama M","year":"2016","unstructured":"Salama M, Amitai Z, Nutman Aet al.Outbreak of adenovirus type 55 infection in Israel. J Clin Virol 2016;78: 31\u201335.","journal-title":"J Clin Virol"},{"key":"e_1_3_2_18_1","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.3201\/eid2211.160728","article-title":"Severe pneumonia associated with adenovirus type 55 infection, France, 2014","volume":"22","author":"Lafolie J","year":"2016","unstructured":"Lafolie J, Mirand A, Salmona Met al.Severe pneumonia associated with adenovirus type 55 infection, France, 2014. Emerg Infect Dis 2016;22: 2012\u20132014.","journal-title":"Emerg Infect Dis"},{"key":"e_1_3_2_19_1","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1128\/JCM.01694-09","article-title":"Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen","volume":"48","author":"Walsh MP","year":"2010","unstructured":"Walsh MP, Seto J, Jones MSet al.Computational analysis identifies human adenovirus type 55 as a re-emergent acute respiratory disease pathogen. J Clin Microbiol 2010;48: 991\u2013993.","journal-title":"J Clin Microbiol"},{"key":"e_1_3_2_20_1","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1378\/chest.13-1186","article-title":"Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia","volume":"145","author":"Cao B","year":"2014","unstructured":"Cao B, Huang G-H, Pu Z-Het al.Emergence of community-acquired adenovirus type 55 as a cause of community-onset pneumonia. Chest 2014;145: 79\u201386.","journal-title":"Chest"},{"key":"e_1_3_2_21_1","doi-asserted-by":"crossref","first-page":"e0160777","DOI":"10.1371\/journal.pone.0160777","article-title":"Sustained viremia and high viral load in respiratory tract secretions are predictors for death in immunocompetent adults with adenovirus pneumonia","volume":"11","author":"Schildgen O","year":"2016","unstructured":"Schildgen O, Gu L, Qu Jet al.Sustained viremia and high viral load in respiratory tract secretions are predictors for death in immunocompetent adults with adenovirus pneumonia. Plos One 2016;11: e0160777.","journal-title":"Plos One"},{"key":"e_1_3_2_22_1","doi-asserted-by":"crossref","first-page":"e100665","DOI":"10.1371\/journal.pone.0100665","article-title":"In vitro characterization of human adenovirus type 55 in comparison with its parental adenoviruses, types 11 and 14","volume":"9","author":"Liu J","year":"2014","unstructured":"Liu J, Nian QG, Zhang Yet al.In vitro characterization of human adenovirus type 55 in comparison with its parental adenoviruses, types 11 and 14. PLoS One 2014;9: e100665.","journal-title":"PLoS One"},{"key":"e_1_3_2_23_1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1128\/JVI.01790-15","article-title":"Low-level expression of the E1B 20-kilodalton protein by adenovirus 14p1 enhances viral immunopathogenesis","volume":"90","author":"Radke JR","year":"2016","unstructured":"Radke JR, Yong SL, Cook JL.Low-level expression of the E1B 20-kilodalton protein by adenovirus 14p1 enhances viral immunopathogenesis. J Virol 2016;90: 497\u2013505.","journal-title":"J Virol"},{"key":"e_1_3_2_24_1","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1089\/104303404322886147","article-title":"Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines","volume":"15","author":"Aste-Amezaga M","year":"2004","unstructured":"Aste-Amezaga M, Bett AJ, Wang Fet al.Quantitative adenovirus neutralization assays based on the secreted alkaline phosphatase reporter gene: application in epidemiologic studies and in the design of adenovector vaccines. Hum Gene Ther 2004;15: 293\u2013304.","journal-title":"Hum Gene Ther"},{"key":"e_1_3_2_25_1","doi-asserted-by":"crossref","first-page":"3837","DOI":"10.1016\/j.vaccine.2011.03.042","article-title":"Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China","volume":"29","author":"Sun C","year":"2011","unstructured":"Sun C, Zhang Y, Feng Let al.Epidemiology of adenovirus type 5 neutralizing antibodies in healthy people and AIDS patients in Guangzhou, southern China. Vaccine 2011;29: 3837\u20133841.","journal-title":"Vaccine"},{"key":"e_1_3_2_26_1","doi-asserted-by":"crossref","first-page":"e0156984","DOI":"10.1371\/journal.pone.0156984","article-title":"Human adenovirus serotype 3 vector packaged by a rare serotype 14 hexon","volume":"11","author":"Su XB","year":"2016","unstructured":"Su XB, Tian XG, Jiang ZXet al.Human adenovirus serotype 3 vector packaged by a rare serotype 14 hexon. Plos One 2016;11: e0156984.","journal-title":"Plos One"},{"key":"e_1_3_2_27_1","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.virol.2012.12.014","article-title":"Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera","volume":"437","author":"Yu B","year":"2013","unstructured":"Yu B, Dong J, Wang Cet al.Characteristics of neutralizing antibodies to adenovirus capsid proteins in human and animal sera. Virology 2013;437: 118\u2013123.","journal-title":"Virology"},{"key":"e_1_3_2_28_1","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/jmv.23546","article-title":"Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults","volume":"85","author":"Zhang S","year":"2013","unstructured":"Zhang S, Huang W, Zhou Xet al.Seroprevalence of neutralizing antibodies to human adenoviruses type-5 and type-26 and chimpanzee adenovirus type-68 in healthy Chinese adults. J Med Virol 2013;85: 1077\u20131084.","journal-title":"J Med Virol"},{"key":"e_1_3_2_29_1","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.1086\/514298","article-title":"Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients","volume":"179","author":"Mupapa K","year":"1999","unstructured":"Mupapa K, Massamba M, Kibadi Ket al.Treatment of Ebola hemorrhagic fever with blood transfusions from convalescent patients. J Infect Dis 1999;179: S18\u2013S23.","journal-title":"J Infect Dis"},{"key":"e_1_3_2_30_1","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1056\/NEJMc070359","article-title":"Treatment with convalescent plasma for influenza A (H5N1) infection","volume":"357","author":"Zhou BP","year":"2007","unstructured":"Zhou BP, Zhong NS, Guan Y.Treatment with convalescent plasma for influenza A (H5N1) infection. N Engl J Med 2007;357: 1450\u20131451.","journal-title":"N Engl J Med"},{"key":"e_1_3_2_31_1","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1016\/j.vaccine.2009.10.145","article-title":"International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials","volume":"28","author":"Mast TC","year":"2010","unstructured":"Mast TC, Kierstead L, Gupta SBet al.International epidemiology of human pre-existing adenovirus (Ad) type-5, type-6, type-26 and type-36 neutralizing antibodies: correlates of high Ad5 titers and implications for potential HIV vaccine trials. Vaccine 2010;28: 950\u2013957.","journal-title":"Vaccine"},{"key":"e_1_3_2_32_1","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1128\/JVI.02696-06","article-title":"Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D","volume":"81","author":"Abbink P","year":"2007","unstructured":"Abbink P, Lemckert AA, Ewald BAet al.Comparative seroprevalence and immunogenicity of six rare serotype recombinant adenovirus vaccine vectors from subgroups B and D. J Virol 2007;81: 4654\u20134663.","journal-title":"J Virol"},{"key":"e_1_3_2_33_1","doi-asserted-by":"crossref","first-page":"3781","DOI":"10.1128\/JCM.01249-06","article-title":"Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa","volume":"44","author":"Thorner AR","year":"2006","unstructured":"Thorner AR, Vogels R, Kaspers Jet al.Age dependence of adenovirus-specific neutralizing antibody titers in individuals from sub-Saharan Africa. J Clin Microbiol 2006;44: 3781\u20133783.","journal-title":"J Clin Microbiol"},{"key":"e_1_3_2_34_1","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.1038\/emi.2014.30","article-title":"Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China","volume":"3","author":"Wang X","year":"2014","unstructured":"Wang X, Xing M, Zhang Cet al.Neutralizing antibody responses to enterovirus and adenovirus in healthy adults in China. Emerg Microbes Infect 2014;3: e30.","journal-title":"Emerg Microbes Infect"},{"key":"e_1_3_2_35_1","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00705-015-2333-2","article-title":"The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China","volume":"160","author":"Huang D","year":"2015","unstructured":"Huang D, Hennequi M, Elvachev Aet al.The sero-prevalence of anti-adenovirus 5 neutralizing antibodies is independent of a chronic hepatitis B carrier state in China. Arch Virol 2015;160: 1125\u20131130.","journal-title":"Arch Virol"},{"key":"e_1_3_2_36_1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1128\/JCM.01928-09","article-title":"Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP","volume":"48","author":"Kajon AE","year":"2010","unstructured":"Kajon AE, Dickson LM, Metzgar Det al.Outbreak of febrile respiratory illness associated with adenovirus 11a infection in a Singapore military training cAMP. J Clin Microbiol 2010;48: 1438\u20131441.","journal-title":"J Clin Microbiol"},{"key":"e_1_3_2_37_1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.21037\/jtd.2016.03.29","article-title":"Prevalence of neutralizing antibodies to common respiratory viruses in intravenous immunoglobulin and in healthy donors in southern China","volume":"8","author":"Tian X","year":"2016","unstructured":"Tian X, Jiang Z, Ma Qet al.Prevalence of neutralizing antibodies to common respiratory viruses in intravenous immunoglobulin and in healthy donors in southern China. J Thorac Dis 2016;8: 803\u2013812.","journal-title":"J Thorac Dis"},{"key":"e_1_3_2_38_1","doi-asserted-by":"crossref","first-page":"5579","DOI":"10.1016\/j.vaccine.2016.09.043","article-title":"Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions","volume":"34","author":"Yang W-X","year":"2016","unstructured":"Yang W-X, Zou X-H, Jiang S-Yet al.Prevalence of serum neutralizing antibodies to adenovirus type 5 (Ad5) and 41 (Ad41) in children is associated with age and sanitary conditions. Vaccine 2016;34: 5579\u20135586.","journal-title":"Vaccine"},{"key":"e_1_3_2_39_1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.7883\/yoken.64.95","article-title":"Norovirus and histo-blood group antigens","volume":"64","author":"Shirato H","year":"2011","unstructured":"Shirato H.Norovirus and histo-blood group antigens. Jpn J Infect Dis 2011;64: 95\u2013103.","journal-title":"Jpn J Infect Dis"},{"key":"e_1_3_2_40_1","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1097\/MOH.0b013e32833ece31","article-title":"Blood groups and susceptibility to virus infection: new developments","volume":"17","author":"Branch DR","year":"2010","unstructured":"Branch DR.Blood groups and susceptibility to virus infection: new developments. Curr Opin Hematol 2010;17: 558\u2013564.","journal-title":"Curr Opin Hematol"},{"key":"e_1_3_2_41_1","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1002\/ijc.26376","article-title":"ABO blood group, hepatitis B viral infection and risk of pancreatic cancer","volume":"131","author":"Wang D-S","year":"2012","unstructured":"Wang D-S, Chen D-L, Ren Cet al.ABO blood group, hepatitis B viral infection and risk of pancreatic cancer. Int J Cancer 2012;131: 461\u2013468.","journal-title":"Int J Cancer"},{"key":"e_1_3_2_42_1","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/nature04721","article-title":"Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity","volume":"441","author":"Roberts DM","year":"2006","unstructured":"Roberts DM, Nanda A, Havenga MJet al.Hexon-chimaeric adenovirus serotype 5 vectors circumvent pre-existing anti-vector immunity. Nature 2006;441: 239\u2013243.","journal-title":"Nature"},{"key":"e_1_3_2_43_1","doi-asserted-by":"crossref","first-page":"7964","DOI":"10.1128\/JVI.07076-11","article-title":"Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions","volume":"86","author":"Qiu H","year":"2012","unstructured":"Qiu H, Li X, Tian Xet al.Serotype-specific neutralizing antibody epitopes of human adenovirus type 3 (HAdV-3) and HAdV-7 reside in multiple hexon hypervariable regions. J Virol 2012;86: 7964\u20137975.","journal-title":"J Virol"},{"key":"e_1_3_2_44_1","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1128\/JVI.06254-11","article-title":"Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection","volume":"86","author":"Bradley RR","year":"2012","unstructured":"Bradley RR, Lynch DM, Iampietro MJet al.Adenovirus serotype 5 neutralizing antibodies target both hexon and fiber following vaccination and natural infection. J Virol 2012;86: 625\u2013629.","journal-title":"J Virol"},{"key":"e_1_3_2_45_1","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1128\/JVI.00866-09","article-title":"Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization","volume":"84","author":"Cheng C","year":"2010","unstructured":"Cheng C, Gall JG, Nason Met al.Differential specificity and immunogenicity of adenovirus type 5 neutralizing antibodies elicited by natural infection or immunization. J Virol 2010;84: 630\u2013638.","journal-title":"J Virol"}],"container-title":["Emerging Microbes & Infections"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.tandfonline.com\/doi\/pdf\/10.1038\/emi.2017.29","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,22]],"date-time":"2023-09-22T12:19:11Z","timestamp":1695385151000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.tandfonline.com\/doi\/full\/10.1038\/emi.2017.29"}},"subtitle":["Prevalence of Ad14 and 55-neutralizing antibodies"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":44,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["10.1038\/emi.2017.29"],"URL":"https:\/\/doi.org\/10.1038\/emi.2017.29","relation":{},"ISSN":["2222-1751"],"issn-type":[{"value":"2222-1751","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"The publishing and review policy for this title is described in its Aims & Scope.","order":1,"name":"peerreview_statement","label":"Peer Review Statement"},{"value":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","URL":"http:\/\/www.tandfonline.com\/action\/journalInformation?show=aimsScope&journalCode=temi20","order":2,"name":"aims_and_scope_url","label":"Aim & Scope"},{"value":"2017-01-09","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2017-03-14","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2019-01-15","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}